Hedge fund billionaire Daniel Loeb assumed a stake in the Life Sciences Tools & Services company Thermo Fisher Scientific Inc (NYSE:TMO) at Third Point LLC in the fourth quarter of FY25.

As of Dec. 31, 2025, Loeb bought 50,000 shares in the company.

Recent Key Events

In February, Thermo Fisher Scientific’s Board approved a quarterly dividend of $0.47 per share, payable on April 15, 2026, to shareholders of record as of March 13, 2026. The new dividend represents a 10% increase from the prior $0.43 payout.

Thermo Fisher Scientific agreed to divest its microbiology business to Astorg for approximately $1.075 billion, including cash and a $50 million seller note.

This month, the company reported first-quarter 2026 adjusted earnings of $5.44 per share, beating the street view of $5.24.

The life science giant's quarterly sales of $11.01 billion increased 6% year-over-year, beating the analyst consensus estimate of $10.85 billion. Organic revenue growth was 1%.

Thermo Fisher Scientific raised its fiscal 2026 adjusted earnings per share guidance from $24.22-$24.80 to $24.64-$25.12 versus the consensus ...